INTRODUCTION
============

Renal transplantation is a successful and widely used treatment for renal insufficiency. Better organ matching, improved surgical techniques, and more effective immunosuppressive drugs have led to a steady increase in graft survival.

Although major technical obstacles have been overcome, strict attention to detail is still mandatory in every phase of the transplantation process from initial recipient evaluation until surgical procedure completion.

Pathological findings of urinary tract can occur in up to 25% of patients with end-stage renal disease ([@B1]). Therefore, urologic surgery may need to be performed before or after renal transplantation.

The present study reviews the outcomes of 23 urologic surgical procedures performed because of de novo urologic diseases in 21 renal transplant recipients.

MATERIALS AND METHODS
=====================

Between January 1986 and January 2001, 281 patients underwent renal transplantation at Kyung Hee University Medical Center. All patients received organs from living related donors. Twenty-one of these patients also underwent urologic surgery before or after renal transplantation because of de novo urologic disease. Patients that required urologic surgery because of complications after renal transplantation were excluded. Urinalysis, urine culture, and urodynamic studies were performed in all patients. In anuric patients, bladder washing for cytology and culture were performed. The urologic physical examinations included an assessment of the bulbocavernous reflex, anal tone, and perineal sensation. The recipients also underwent voiding cystourethrography prior to renal transplantation. Renal function was followed postoperatively by monitoring serum creatinine and urine output. Additional imaging studies were done according to clinical need.

RESULTS
=======

Patient characteristics
-----------------------

Overall, 21 patients (7.4%) underwent 23 urologic surgeries because of de novo urologic disease. Mean patient age was 38.1 yr. Nine patients were male and 12 were female, and all recipients received grafts from related donors.

Urologic surgery before renal transplantation
---------------------------------------------

Nineteen urologic surgical procedures were performed on 17 patients prior to renal transplantation, and these procedures were done an average 2.9 months (range, 0-8 months) before transplantation. Two patients underwent dual surgery, i.e., bilateral nephroureterectomy with augmentation enterocystoplasty for bilateral vesicoureteral reflux (VUR) with a contracted bladder, and ileal diversion with bilateral nephroureterectomy for a neuropathic bladder with bilateral VUR. Bilateral nephrectomy was done in 7 patients with extremely large polycystic kidneys. Four of the 7 patients had recurrent bleeding into cysts, pain, and an extremely large kidney. One of these patients expired due to postoperative uncontrolled bleeding. Bilateral nephroureterectomy was performed in 6 patients with bilateral VUR and recurrent urinary tract infections. One of these six expired due to postoperative bleeding. The mortality rate was 10.5% in the patients with urologic surgery before renal transplantation. Ileal urinary diversion without cystectomy was done in 3 female patients for a contracted or neuropathic bladder. These diversions were performed at the same time as the renal transplantation ([Table 1](#T1){ref-type="table"}).

Urologic surgery after renal transplantation
--------------------------------------------

Four patients underwent urologic surgery an average 57.5 months (range, 2-122 months) after transplantation. One patient with recurrent urinary tract infection for VUR had a nephroureterectomy 48 months after renal transplantation, and simple nephrectomy was performed 122 months after renal transplantation in a patient with spontaneous rupture of an end-stage native kidney. Bilateral orchiopexy was performed in a 9-yr old patient who had undergone renal transplantation some 4 yr previously. One patient underwent transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) because of voiding difficulties that were aggravated after renal transplantation ([Table 2](#T2){ref-type="table"}).

We experienced one case of renal cell carcinoma in an endstage native kidney 25 months after transplantation. However, the patient refused surgery and the case details are not included in this study.

Result of urologic surgery
--------------------------

Two patients expired due to postoperative uncontrolled bleeding from bilateral nephrectomy for a polycystic kidney and bilateral nephrectomy for bilateral VUR, respectively. After ileal diversion with renal transplantation, one patient had a normal vaginal delivery. After transplantation, the two patients died due to chronic rejection with pericardial effusion and sepsis, respectively. However, graft survival was good in the other 21 patients ([Table 3](#T3){ref-type="table"}).

DISCUSSION
==========

Renal transplantation is the best available therapy for most patients with end-stage renal disease. The pre-transplantation goal of the urologist is to optimize the condition of the urinary tract, which should be sterile, continent, and compliant before donor kidney transplantation ([@B2]).

Transplantation candidates may have undetected urologic abnormalities, and clinical symptoms that are minimal preoperatively can be exacerbated after the restoration of renal function by successful transplantation. If correction is considered, it is recommended that all anomalies should be repaired before transplantation to allow for proper healing before the patient is placed on immunosuppression ([@B3]). Many reports indicate that an abnormal lower urinary bladder or posterior urethral valves are no longer a contraindication to renal transplantation, as patients with lower urinary tract anomalies have previously been considered poor candidates for renal transplantation. However, newer techniques of diagnosis and reconstructive urologic surgery have extended the indications and improved the success rate of renal transplantation in these patients ([@B4]-[@B6]). Infection sources should be controlled to prevent a flare-up and possible septicemia that may occur after the initiation of immunosuppressive therapy with transplantation. In the present study, patients with VUR were corrected before transplantation, because they could incur septicemia during immunosuppressive therapy.

The indications for bilateral nephrectomy in patients with autosomal dominant polycystic kidney disease are recurrent infection, bleeding into cysts, and a huge kidney that interferes with pulmonary function ([@B7]). However, Stiasny et al. ([@B8]) found that overall patient and graft survival rates did not differ between those with and without a polycystic kidney. As urinary tract infection and lethal septicemia were the leading complications in patients with a polycystic kidney, careful monitoring for infections is important during the post-transplant follow-up. Four of 7 patients with polycystic kidney in our cases had bleeding into cysts and an extremely enlarged polycystic kidney; therefore, we performed bilateral nephrectomy.

Restoration of the urinary tract by urinary diversion, or augmentation enterocystoplasty should be also considered in patients with neurogenic bladder or in those with a contracted bladder ([@B9], [@B10]).

Natarajan et al. ([@B11]) reported successful pregnancy in patients with urinary diversion. In our study, one patient achieved a successful vaginal delivery. She underwent ileal urinary diversion at the time of her renal transplantation.

Reinberg et al. ([@B12]) recommended that nephrectomy should be performed 6 weeks to 3 months before transplantation, but not before the urethral procedure, to prevent dry urethral syndrome. We performed urologic surgery successfully 2.9 months before transplantation and obtained good result. However, perioperative morbidity and mortality rates are elevated in patients with uremia. Cardiovascular disease is the most common cause of death in patients with renal disease ([@B13]) and bleeding tendency is also another significant risk factor. The most common hemorrhagic manifestations in uremia are prolonged bleeding from operation site, and this kind bleeding is exacerbated by anticoagulation therapy during hemodialysis ([@B14]). In the present study, two patients expired due to postoperative bleeding. To reduce mortality and morbidity, increased bleeding related to uremic platelet dysfunction can be managed by the administration of desmopressin, cryoprecipitate, or estrogens, and by avoiding the use of medication with antiplatelets close to the time of surgery. Hyperkalemia can be temporarily improved by the intravenous administration of an insulin-dextrose combination or bicarbonate, and polystyrene binding resins or dialysis can remove excess potassium stores ([@B15]).

Spontaneous renal allograft rupture has been occasionally reported ([@B16]). However, the rupture of an end-stage native kidney is relatively rare. Piccoli et al. ([@B17]) reported spontaneous renal rupture in a patient with acquired cystic kidney disease (ACKD) on hemodialysis. We performed emergency nephrectomy on a patient with a ruptured native kidney 122 months after transplantation. However, this is a life-threatening condition, and many recipients have ACKD. Therefore, close follow-up is needed for these patients. TURP can be performed before or after renal transplantation. However, Shenaky ([@B18]) reported that TURP in the patient with BPH might lead to bladder neck contracture or urethral scarring with recurrent stenosis, if it is performed before the reestablishment of urine flow by transplantation. Reinberg et al. ([@B19]) found that TURP can be safely performed immediately after renal transplantation only if; urine is sterile, antibiotics and steroids are carefully administered perioperatively, low-gravity irrigation is used, and hemostasis is meticulous. We performed TURP 2 months after renal transplantation without any incident, although renal cell carcinoma was detected 25 months after transplantation in a single patient. Surgery was not performed in this case because of patient refusal.

From the results of the present study, we conclude that the major reasons for urologic surgery in recipients are polycystic kidney disease, VUR, and dysfunctional voiding disorders. Surgical correction, with the exception of urethral surgery, should be performed at least 3 months before renal transplantation. However, it must be recognized that patients with uremia are vulnerable to surgical complications due to a bleeding tendency, although urologic surgery was not found to influence graft survival. We also conclude that more intensive long-term urologic follow-up must be undertaken for recipients.
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Urologic surgery performed in recipients before renal transplantation
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RT, renal transplantation.
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Urologic surgery performed in recipients after renal transplantation
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BPH, benign prostatic hyperplasia; RT, renal transplantation; TURP, transurethral resection of the prostate; UTI, urinary tract infection; VUR, vesicoureteral reflux.
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Results of urologic surgery conducted before or after renal transplantation
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RT, renal transplantation; VUR, vesicoureteral reflux; BPH, benign prostatic hyperplasia; TURP, transurethral resection of prostate; pt, patient.
